ClinConnect ClinConnect Logo
Search / Trial NCT06854068

Evaluation of the Combined Effect of Bioactive Toothpastes, Desensitizing Agents and Er-YAG Laser on Dentin Hypersensitivity: an In-Vivo Study

Launched by EGE UNIVERSITY · Feb 25, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Dentin Hypersensitivity Laser Desensitization Agent Toothpaste

ClinConnect Summary

This clinical trial is looking at different treatments for dentin hypersensitivity, which is a common problem where teeth feel painful or sensitive to hot, cold, or sweet things. Researchers want to find out if using special toothpastes, desensitizing agents, and a specific type of laser treatment can help reduce this sensitivity. They will also check to see if these treatments cause any side effects.

To participate in the study, you need to be at least 18 years old, have good oral hygiene, and experience sensitivity in at least three teeth. If you join, you will be placed in one of four groups and receive two treatment sessions, one week apart. After that, you’ll have follow-up visits to check how well the treatments are working. This study is not yet recruiting participants, but it aims to find the best way to manage dentin hypersensitivity effectively and safely.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Individuals over the age of 18,
  • 2. Individuals with good oral hygiene,
  • 3. Individuals without systemic contraindications for treatment,
  • 4. Individuals who are reliable for periodic follow-ups, cooperative, and willing to participate in the study,
  • 5. Individuals with sensitivity in at least three teeth,
  • 6. Individuals who have been using a standard toothpaste containing 1100 ppm fluoride for at least one month.
  • Exclusion Criteria:
  • 1. Individuals with a history of alcohol, drug, or medication addiction,
  • 2. Individuals known to be unable to attend follow-up sessions,
  • 3. Individuals with allergies to any of the products used in the study,
  • 4. Individuals with unstable mental or physical conditions,
  • 5. Pregnant or breastfeeding individuals, as well as those planning pregnancy during the study.

About Ege University

Ege University, a prestigious institution located in Izmir, Turkey, is renowned for its commitment to advancing medical research and education. As a prominent clinical trial sponsor, Ege University leverages its extensive academic resources and expertise in various healthcare fields to facilitate innovative clinical studies. The university is dedicated to enhancing patient care through rigorous research methodologies and collaboration with multidisciplinary teams, ensuring the development of effective therapies and interventions. With a strong focus on ethical standards and regulatory compliance, Ege University aims to contribute significantly to the global medical community by fostering groundbreaking discoveries and improving health outcomes.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported